Physicians prescribed significantly more guideline-directed medications for heart failure if they received a customized digital alert via an electronic health record (EHR) system when inputting medical orders shortly after seeing a patient, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
April 08, 2022
Electronic Alert Improves Guideline Adherence for Heart Failure Treatment
April 8, 2022 – Physicians prescribed significantly more guideline-directed medications for heart failure if they…
Read More
Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent the body from absorbing too much potassium—compared with a placebo, in a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
April 08, 2022
Patiromer Helps Patients Stay on Optimal Heart Failure Therapy
April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure…
Read More
Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less structural deterioration in the valve after five years compared with similar patients who had the biologic valve inserted surgically.
April 08, 2022
Rate of Structural Valve Deterioration Lower with TAVR than with SAVR
April 8, 2022 – Patients who received a transcatheter supra-annular self-expanding heart valve had significantly less…
Read More
The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports continuing improvements in quality care delivery for heart attacks in low- and middle-income countries with the use of data collection and localized education around guideline-directed medical therapy, according to data from the program’s second year.
April 07, 2022
ACC Program sees Improvement in Global Heart Attack Care
April 7, 2022 – The American College of Cardiology’s Global Heart Attack Treatment Initiative (GHATI) reports…
Read More
ADAPT-TAVR Trial
April 07, 2022
No Reduction in Stroke, Mini Strokes, Blood Clotting in the Brain or Changes in Cognitive Function with Edoxaban After TAVR
April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement…
Read More
Tricuspid valve
April 07, 2022
Tricuspid Valve Repair System Shows Promising Results at One-year Follow-up
April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who…
Read More
Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a multifaceted strategy to try to keep their blood pressure from dropping to a potentially dangerous low level immediately before, during and for up to two days after surgery made no difference in the rates of major cardiovascular events in the 30 days following surgery.
April 07, 2022
Blood Pressure Management Strategy During Surgery Has No Impact on Major Cardiovascular Complications
April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a…
Read More
While there are effective therapies to reduce the risk of heart disease by lowering low-density lipoprotein (LDL), or “bad” cholesterol, and other lipids, to date there are no approved treatments to lower lipoprotein(a), a lesser-known driver of heart disease risk.
April 06, 2022
SLN360 Markedly Reduces Lipoprotein(a), an Important Cause of Heart Disease
April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density…
Read More
Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI).
April 06, 2022
Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis…
Read More
Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were 25% lower in 2021 than in 2020, and no deaths occurred among patients who had been vaccinated against COVID-19, according to data presented at the American College of Cardiology’s 71st Annual Scientific Session.
April 06, 2022
In-Hospital Deaths in STEMI Patients With COVID-19 Drop in 2021
April 6, 2022 – Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were…
Read More
Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (CHF) patients, announced results of a clinical study demonstrating the efficacy of its contact-free technology for the detection of pulmonary congestion at home.
April 06, 2022
Study Demonstrates Efficacy of Contact-Free Tech for Pulmonary Congestion Detection at Home
April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (…
Read More
Brigitta Brott, M.D., and Ho-Wook Jun, Ph.D.
April 06, 2022
NIH Grant to UAB will Fund Study of Safer, More Durable Stents
April 6, 2022 – Narrowed arteries can restrict blood flow to the heart. One treatment is inserting a stent — a small…
Read More
According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE) sequence performed higher than the current standard of 1.5-T SSFP for unenhanced coronary MRA, which could help expand clinical adoption of the procedure.
April 06, 2022
Dixon GRE Technique Outperforms Clinical Standard for Unenhanced Coronary MRA
April 6, 2022 – According to ARRS’ American Journal of Roentgenology (AJR), the 3-T Dixon gradient-recalled echo (GRE)…
Read More
Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19 disease. However, it can also be induced by medication, toxic substances or in the context of a rheumatological disease.
April 06, 2022
AI Enables Personalized Treatment of Myocarditis
April 6, 2022 – Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19…
Read More
Kartik Balachandran
April 06, 2022
NIH Awards $437,000 to Study Effects of COVID on Aortic Valve
April 6, 2022 – The National Institute of Health awarded $436,642 to associate professor of biomedical engineering,…
Read More
Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients in the U.S. with slow heart rhythms.
April 05, 2022
Abbott Receives FDA Approval for Aveir VR Leadless Pacemaker System
April 5, 2022 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber…
Read More
GE Healthcare and AliveCor have announced a partnership to deliver medical-grade six-lead electrocardiograms (ECGs) taken by patients on an AliveCor KardiaMobile 6L ECG device outside of the hospital setting – at home or on the go – directly into GE Healthcare’s MUSE Cardiac Management System for physicians to view and evaluate.
April 04, 2022
GE Healthcare and AliveCor Integrate Data from ECGs Into Clinical Workflow
April 4, 2022 – GE Healthcare and AliveCor have announced a partnership to deliver medical-grade six-lead…
Read More
The American College of Cardiology's Evolving Practice of Cardiovascular Precision Medicine course on May 13, 2022 will feature an opening session that includes Geoffrey Ginsburg, MD, PhD and Joshua C. Denny, MD, MS.
April 04, 2022
ACC Course Provides Updates from NIH's All of Us Research Program
April 4, 2022 – The American College of Cardiology's Evolving Practice of Cardiovascular Precision Medicine course on…
Read More
A stroke patient performing upper limb robotic therapy
April 04, 2022
Researchers Examine Impact of Robotic Assistance Level in the Upper Limb Rehabilitation of Stroke Survivors
April 4, 2022 – Researches at the Department of Occupational Therapy, College of Health and Human Sciences, Osaka…
Read More
Keck Medicine of USC has launched its COVID Recovery Clinic, a multidisciplinary program led by a core team of clinicians specializing in primary care, pulmonology and physical therapy.
April 04, 2022
Keck Medicine of USC Launches COVID Recovery Clinic to Treat Patients with Long COVID-19
April 4, 2022 – Keck Medicine of USC has launched its COVID Recovery Clinic, a multidisciplinary program led by a core…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now